95 results
Page 3 of 5
8-K
EX-99.1
uh4qnmk 36g
1 Feb 12
AspenBio Sets 2012 AppyScore Anticipated Milestones; Sees Pivotal Clinical Trial for Appendicitis Test Beginning Mid-2012
12:00am
8-K
EX-99.1
7foh5rflpr682r nyo7h
28 Dec 11
AspenBio Announces Registered Direct Offering of Approximately $1.6 Million
12:00am
8-K
EX-99.2
q25140
29 Nov 11
Important Cautions Regarding Forward-Looking Statements
12:00am
8-K
EX-99.1
o1yid9x3 gqtskckl
29 Nov 11
Important Cautions Regarding Forward-Looking Statements
12:00am
8-K
EX-99.1
6oaz81fcs22y 8ctuptm
31 Oct 11
Important Cautions Regarding Forward-Looking Statements
12:00am
8-K
EX-99.2
a32fc7mc84sftgiq92r
31 Oct 11
Important Cautions Regarding Forward-Looking Statements
12:00am
8-K
EX-99.1
7v5rdvm2j4sm8of9a
20 Oct 11
AspenBio Reports Interim Data from AppyScore Pilot Study and Outlook for Regulatory Pathway
12:00am
8-K
EX-99.1
xe74nygite2qy2
21 Jul 11
Other Events
12:00am
8-K
EX-99.1
bid341
19 Jul 11
Other Events
12:00am
8-K
tdqxgbi4bk9nh
10 Jan 11
Regulation FD Disclosure
12:00am
8-K
EX-99.1
k4p7oghb4nw1t2yquc
20 Jul 10
AspenBio Pharma Reports AppyScore™ ELISA-based Pivotal Trial Results and Outlines Plans for AppyScore Cassette-based Test
12:00am
8-K
EX-99.1
zahn22
7 Jun 10
AspenBio Pharma Updates on AppyScore™ FDA 510(k) Filing and Data Analysis
12:00am
424B5
xg1nuz c6
30 Apr 10
Prospectus supplement for primary offering
12:00am